Table 2.
Prescription, regular medication, and exacerbation history of patients with AECOPD
| n | % | ||
|---|---|---|---|
| Regular medication | LAMA | 13 | 9.4 |
| LABA | 4 | 2.9 | |
| ICS+LABA | 16 | 11.6 | |
| Triple therapy | 63 | 45.7 | |
| Theophylline | 1 | 0.7 | |
| LABA+LAMA | 27 | 19.6 | |
| SABA+SAMA by nebulizer | 14 | 10.1 | |
| Acute exacerbation type | Severe | 46 | 33.3 |
| Moderate | 43 | 31.2 | |
| Mild | 49 | 35.5 | |
| Antibiotic prescription | Appropriate | 88 | 63.8 |
| Inappropriate | 50 | 36.2 | |
| Antibiotic type | Penicillin | 12 | 8.7 |
| Cephalosporin | 33 | 23.9 | |
| Quinolones | 44 | 31.9 | |
| Macrolides | 49 | 35.5 | |
| Exacerbations ≥2 | 40 | 29.0 | |
| Hospitalizations ≥1 | 21 | 15.2 |
ICS: inhaled corticosteroids; LABA: long acting B2 agonists; LAMA: long acting antimuscarinic agent; SABA: short acting B2 agonists; SAMA: short acting antimuscarinic agent; Triple therapy: LAMA+LABA+ICS